Reducing hospital admissions for asthmaticsMedical XpressChildren with moderate or severe asthma attacks who are treated with systemic corticosteroids during the first 75 minutes of triage in the Emergency Department (ED) were 16% less likely to be adm…
Synta Announces Results on Ganetespib Across a Range of Malignancies at the …MarketWatch (press release)In an effort to maximize antitumor activity ganetespib was further combined with PI3K/mTOR inhibitors. As single agents, ganetespib effectively bl…
MDA Awards $120000 to Catabasis PharmaceuticalsMarketWatch (press release)In a previous MDA-supported mouse study, the compound was compared with the corticosteroid prednisolone (similar to prednisone). In the study, CAT-1004 worked as well as predniso…
New Leadership Team for Ipsen Operations in North America to Drive Growth in …MarketWatch (press release)Somatuline® Depot may decrease the bioavailability of cyclosporine. Cyclosporine dose may need to be adjusted to maintain levels. Patients recei…
Novartis expands transplant portfolio with first branded generic tacrolimusThe Pharma LetterSwiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus) capsules, the first generic tacrolimus that can be prescrib…
Doctor TipsterStudy Describes Rapamycin Diabetic-Like State Side Effect MechanismDoctor TipsterRapamycin or sirolimus is actually a macrolide for the first time extracted from the bacterium Streptomyces hygroscopicus present in soil from Easter Island….
MedPage TodayNew Tx Sought for Resistant Kawasaki DiseaseMedPage TodayIn most centers, the initial second-line approach has been to give a second course of IVIG, with subsequent options including steroids, cyclosporine, and infliximab. "For steroi…
Guest Post: Prometheus v Mayo – A European viewPatently-OThe forward references of the '633 patent include US 7524851, whose equivalent EP-B-1695092 has a main claim that reads: wherein a concentration ratio greater than 0.85 is indicative of sup…
TWENTE published: Resolute matches Xience V stentTheHeart.OrgEnschede, the Netherlands – Data from the TWENTE trial, a study showing that the Resolute zotarolimus-eluting stent (Medtronic) was noninferior to the Xience everolimus-eluting stent (Abbott)…
Novartis Expands Transplant Portfolio With Hecoria, the First Generic …PharmaLive.com (press release)East Hanover, NJ, April 2, 2012 — Novartis today announced the US introduction and availability of Hecoria® (tacrolimus) capsules, the first gener…